Talaris Therapeutics is a late-clinical stage biotechnology company based in Boston, MA and Louisville, KY. Talaris is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe auto-immune and immune-mediated disorders.

Biotechnology

Talaris Therapeutics

Yiming Huang

Ken Abrams

Talaris Therapeutics

Org chart

Teams

Leadership Team

Board of Directors

CEO and Executive Team

Similar companies